skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Based on my portfolio review, I need to increase my pharmaceutical weighing. Although you do not follow US companies closely, could you give me your best recommendations for 3 US pharmaceutical Companies. My only holding at the moment is Pfizer. Could you give me your opinion on this company please?
Read Answer Asked by jacques on October 09, 2019
Q: Celgene appears to be stumbling higher, presumably towards the value assigned to it from the Bristol Myers merger. In past months, you previously suggested holding on; is that still your view? Also, can you suggest a source for information on the tax treatment from the merger for Canadian taxpayers who hold Celgene? Thanks,
Read Answer Asked by Leonard on March 20, 2019
Q: hello 5i:
given that US Health Care is not your specialty, and given that the 3 companies occupy different sectors in health care, could you give me your pick as to which of the three you like best using safety first, and growth second as criteria (I do realize that growth and safety create a conundrum of sorts).
thanks
Paul L
Read Answer Asked by Paul on November 05, 2018
Q: I still like Celgene, but I'm considering harvesting a tax loss on it. What pharma stocks would you recommend I replace it with? Or would you wait the 30 days and hope to buy CELG back at a similar level again? I think every ounce of bad news is baked into it and so it might have some big upside if things like the patent fight on Revlimid work out in CELG's favor.
Read Answer Asked by Alex on October 19, 2018
Q: Good morning. I currently have about 7% in healthcare consisting of GUD (4%) and CELG (3%). I'm considering selling CELG and buying CSH.UN. Do you see this as a good trade? Or alternatively, I could go overweight healthcare and hold all 3...thoughts?
Thanks.
Read Answer Asked by Ian on December 18, 2017